Send to

Choose Destination
Mol Pharm. 2016 May 2;13(5):1445-54. doi: 10.1021/acs.molpharmaceut.5b00982. Epub 2016 Mar 29.

Applications of Deep Learning in Biomedicine.

Author information

Artificial Intelligence Research, Insilico Medicine, Inc, ETC, Johns Hopkins University , Baltimore, Maryland 21218, United States.
RedZebra Analytics , 1 Quality Court, London, WC2A 1HR, U.K.


Increases in throughput and installed base of biomedical research equipment led to a massive accumulation of -omics data known to be highly variable, high-dimensional, and sourced from multiple often incompatible data platforms. While this data may be useful for biomarker identification and drug discovery, the bulk of it remains underutilized. Deep neural networks (DNNs) are efficient algorithms based on the use of compositional layers of neurons, with advantages well matched to the challenges -omics data presents. While achieving state-of-the-art results and even surpassing human accuracy in many challenging tasks, the adoption of deep learning in biomedicine has been comparatively slow. Here, we discuss key features of deep learning that may give this approach an edge over other machine learning methods. We then consider limitations and review a number of applications of deep learning in biomedical studies demonstrating proof of concept and practical utility.


RBM; artificial intelligence; biomarker development; deep learning; deep neural networks; genomics; transcriptomics

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center